CNAM
TMO icon

Campbell Newman Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Campbell Newman Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908K Sell
1,811
-822
-31% -$395K 0.07% 79
2026
Q1 		$1.29M Hold
2,633
– – 0.11% 79
2025
Q4 		$1.53M Sell
2,633
-14
-0.5% -$7.92K 0.11% 80
2025
Q3 		$1.28M Buy
2,647
+9
+0.3% +$4.19K 0.09% 86
2025
Q2 		$1.07M Sell
2,638
-6
-0.2% -$2.51K 0.09% 89
2025
Q1 		$1.32M Hold
2,644
– – 0.11% 82
2024
Q4 		$1.38M Sell
2,644
-37
-1% -$20.3K 0.11% 81
2024
Q3 		$1.66M Sell
2,681
-112
-4% -$66.3K 0.12% 77
2024
Q2 		$1.54M Sell
2,793
-6
-0.2% -$3.44K 0.12% 75
2024
Q1 		$1.63M Sell
2,799
-10
-0.4% -$5.61K 0.13% 72
2023
Q4 		$1.49M Buy
2,809
+13
+0.5% +$6.29K 0.13% 73
2023
Q3 		$1.42M Sell
2,796
-5
-0.2% -$2.66K 0.13% 72
2023
Q2 		$1.46M Sell
2,801
-24
-0.8% -$13K 0.13% 69
2023
Q1 		$1.63M Sell
2,825
-1
-0% -$564 0.16% 61
2022
Q4 		$1.56M Sell
2,826
-23
-0.8% -$12.2K 0.15% 63
2022
Q3 		$1.45M Sell
2,849
-3
-0.1% -$1.68K 0.16% 60
2022
Q2 		$1.55M Sell
2,852
-25
-0.9% -$13.8K 0.16% 60
2022
Q1 		$1.7M Sell
2,877
-3
-0.1% -$1.72K 0.16% 62
2021
Q4 		$1.92M Sell
2,880
-21
-0.7% -$13.1K 0.17% 61
2021
Q3 		$1.66M Sell
2,901
-9
-0.3% -$4.94K 0.17% 62
2021
Q2 		$1.47M Sell
2,910
-514
-15% -$243K 0.14% 71
2021
Q1 		$1.56M Sell
3,424
-276
-7% -$132K 0.16% 64
2020
Q4 		$1.72M Sell
3,700
-1,508
-29% -$707K 0.2% 56
2020
Q3 		$2.3M Sell
5,208
-41
-0.8% -$16.9K 0.29% 46
2020
Q2 		$1.9M Sell
5,249
-19
-0.4% -$6.37K 0.26% 46
2020
Q1 		$1.49M Buy
5,268
+151
+3% +$47.6K 0.26% 50
2019
Q4 		$1.66M Sell
5,117
-40
-0.8% -$12.1K 0.22% 54
2019
Q3 		$1.5M Sell
5,157
-22
-0.4% -$6.3K 0.22% 54
2019
Q2 		$1.52M Sell
5,179
-24
-0.5% -$6.61K 0.22% 53
2019
Q1 		$1.42M Buy
5,203
+137
+3% +$34.1K 0.22% 54
2018
Q4 		$1.13M Buy
5,066
+58
+1% +$13.6K 0.2% 58
2018
Q3 		$1.22M Buy
5,008
+140
+3% +$32.2K 0.18% 61
2018
Q2 		$1.01M Sell
4,868
-108
-2% -$22.9K 0.16% 62
2018
Q1 		$1.03M Buy
4,976
+755
+18% +$158K 0.17% 62
2017
Q4 		$801K Buy
4,221
+317
+8% +$60.7K 0.14% 73
2017
Q3 		$739K Buy
3,904
+48
+1% +$8.69K 0.13% 73
2017
Q2 		$673K Hold
3,856
– – 0.12% 74
2017
Q1 		$592K Sell
3,856
-26
-0.7% -$3.97K 0.11% 76
2016
Q4 		$548K Sell
3,882
-64
-2% -$9.44K 0.11% 77
2016
Q3 		$628K Sell
3,946
-448
-10% -$69K 0.11% 74
2016
Q2 		$649K Sell
4,394
-246
-5% -$36.3K 0.12% 77
2016
Q1 		$657K Buy
+4,640
New +$622K 0.14% 57

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Campbell Newman Asset Management's TMO Position: Q2 2026 in Review

Campbell Newman Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 31% in Q2 2026, selling an estimated $395K and leaving 1,811 shares worth $908K. The position accounts for 0.07% of the portfolio, ranked #79.

Campbell Newman Asset Management first reported a position in TMO in Q1 2016 and has held it in 42 quarters since. The position peaked at $2.3M in Q3 2020. 814 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Campbell Newman Asset Management held 1,811 shares of Thermo Fisher Scientific worth $908K as of Q2 2026.
  • Campbell Newman Asset Management sold 822 Thermo Fisher Scientific shares in Q2 2026, an estimated $395K.
  • Thermo Fisher Scientific made up 0.07% of Campbell Newman Asset Management's portfolio in Q2 2026, its #79 holding.
  • Campbell Newman Asset Management first reported a position in Thermo Fisher Scientific in Q1 2016 and has held it in 42 quarters since.
  • Campbell Newman Asset Management's Thermo Fisher Scientific position peaked at $2.3M in Q3 2020.
  • 814 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Campbell Newman Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.